The NHS is urging around 1.3 million older people who have not yet had the respiratory syncytial virus vaccine to get jabbed, as health service chiefs warn it is “not just a winter illness”. Invites ...

More than 1.3 million older people will be invited to get the vaccine in the coming days, NHS England has said. Adults over ...

MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory syncytial virus (RSV) – a cold-like illness that can make some ...

This urgent plea coincides with NHS England raising alarms about hospital capacities, dubbing this period as potentially the ...

Health officials have warned that people need to be protected against respiratory syncytial virus (RSV) by the vaccine.

Michigan's largest health system urges patients to seek nonemergency care at sites other than its ERs amid a surge in flu, ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

This nasty illness can develop into severe lung infections like pneumonia or other life-threatening conditions, with the elderly most vulnerable ...

Pregnant women across the Northern Territory now have free access to protection against the leading cause of hospitalisation ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...